McKesson Current Ratio 2010-2025 | MCK
Current and historical current ratio for McKesson (MCK) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. McKesson current ratio for the three months ending June 30, 2025 was 0.88.
| McKesson Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2025-06-30 |
$56.80B |
$64.33B |
0.88 |
| 2025-03-31 |
$55.40B |
$61.60B |
0.90 |
| 2024-12-31 |
$51.74B |
$58.56B |
0.88 |
| 2024-09-30 |
$53.34B |
$58.77B |
0.91 |
| 2024-06-30 |
$52.25B |
$56.43B |
0.93 |
| 2024-03-31 |
$47.97B |
$52.36B |
0.92 |
| 2023-12-31 |
$47.64B |
$51.66B |
0.92 |
| 2023-09-30 |
$47.53B |
$51.15B |
0.93 |
| 2023-06-30 |
$45.54B |
$48.42B |
0.94 |
| 2023-03-31 |
$44.29B |
$47.96B |
0.92 |
| 2022-12-31 |
$44.66B |
$48.01B |
0.93 |
| 2022-09-30 |
$46.45B |
$48.36B |
0.96 |
| 2022-06-30 |
$45.38B |
$47.20B |
0.96 |
| 2022-03-31 |
$46.23B |
$48.47B |
0.95 |
| 2021-12-31 |
$46.50B |
$47.45B |
0.98 |
| 2021-09-30 |
$45.58B |
$46.08B |
0.99 |
| 2021-06-30 |
$43.35B |
$43.84B |
0.99 |
| 2021-03-31 |
$45.38B |
$44.10B |
1.03 |
| 2020-12-31 |
$42.37B |
$41.93B |
1.01 |
| 2020-09-30 |
$42.35B |
$42.72B |
0.99 |
| 2020-06-30 |
$38.68B |
$38.60B |
1.00 |
| 2020-03-31 |
$42.22B |
$42.62B |
0.99 |
| 2019-12-31 |
$39.39B |
$40.06B |
0.98 |
| 2019-09-30 |
$37.35B |
$37.15B |
1.01 |
| 2019-06-30 |
$38.43B |
$37.95B |
1.01 |
| 2019-03-31 |
$38.47B |
$37.63B |
1.02 |
| 2018-12-31 |
$38.32B |
$37.42B |
1.02 |
| 2018-09-30 |
$38.54B |
$38.86B |
0.99 |
| 2018-06-30 |
$38.21B |
$38.35B |
1.00 |
| 2018-03-31 |
$37.14B |
$36.69B |
1.01 |
| 2017-12-31 |
$40.20B |
$37.65B |
1.07 |
| 2017-09-30 |
$39.79B |
$37.77B |
1.05 |
| 2017-06-30 |
$37.70B |
$35.80B |
1.05 |
| 2017-03-31 |
$36.95B |
$35.61B |
1.04 |
| 2016-12-31 |
$39.27B |
$38.17B |
1.03 |
| 2016-09-30 |
$41.34B |
$37.05B |
1.12 |
| 2016-06-30 |
$39.04B |
$36.57B |
1.07 |
| 2016-03-31 |
$38.44B |
$35.07B |
1.10 |
| 2015-12-31 |
$38.26B |
$34.48B |
1.11 |
| 2015-09-30 |
$38.75B |
$34.78B |
1.11 |
| 2015-06-30 |
$38.57B |
$34.67B |
1.11 |
| 2015-03-31 |
$36.67B |
$33.50B |
1.10 |
| 2014-12-31 |
$37.14B |
$32.78B |
1.13 |
| 2014-09-30 |
$33.88B |
$29.34B |
1.16 |
| 2014-06-30 |
$33.97B |
$29.25B |
1.16 |
| 2014-03-31 |
$32.84B |
$29.62B |
1.11 |
| 2013-12-31 |
$25.23B |
$21.90B |
1.15 |
| 2013-09-30 |
$24.55B |
$21.38B |
1.15 |
| 2013-06-30 |
$24.07B |
$21.48B |
1.12 |
| 2013-03-31 |
$23.17B |
$21.36B |
1.09 |
| 2012-12-31 |
$23.44B |
$20.21B |
1.16 |
| 2012-09-30 |
$23.09B |
$20.75B |
1.11 |
| 2012-06-30 |
$22.05B |
$20.10B |
1.10 |
| 2012-03-31 |
$23.60B |
$21.69B |
1.09 |
| 2011-12-31 |
$24.57B |
$20.72B |
1.19 |
| 2011-09-30 |
$23.26B |
$19.85B |
1.17 |
| 2011-06-30 |
$22.37B |
$19.14B |
1.17 |
| 2011-03-31 |
$22.36B |
$18.73B |
1.19 |
| 2010-12-31 |
$21.69B |
$19.69B |
1.10 |
| 2010-09-30 |
$20.24B |
$16.39B |
1.24 |
| 2010-06-30 |
$20.79B |
$16.89B |
1.23 |
| 2010-03-31 |
$21.50B |
$17.01B |
1.26 |
| 2009-12-31 |
$20.85B |
$16.92B |
1.23 |
| 2009-09-30 |
$19.93B |
$16.42B |
1.21 |
| 2009-06-30 |
$19.06B |
$15.94B |
1.20 |
| 2009-03-31 |
$18.67B |
$15.61B |
1.20 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$84.197B |
$359.051B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
